Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07292272 · ClinicalTrials.gov registry record · NA

Halt Aging in Survivors of Blood Cancers

A NA study, sponsored by University of Nebraska.

Recruiting
Registry status
NA
Development phase
180
Enrollment target

NCT07292272 is a NA study that is actively recruiting participants, run by University of Nebraska. The registered enrollment target is 180 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07292272, a NA study, is actively recruiting participants, sponsored by University of Nebraska.

RECRUITING
Registry status
NA
Development phase
180 participants
Enrollment target

Study Summary

Older survivors of blood cancer are at a high risk of accelerated biological aging, which increases their risk of developing multiple aging-related conditions. Whereas physical exercise can improve overall health, older cancer survivors do not meet the recommended physical activity, highlighting the need to develop behavioral interventions to increase adherence. Several other knowledge gaps exist to implement exercise interventions in older survivors of blood cancer; the dose and duration of exercise necessary to slow biological aging in older blood cancer survivors remain unknown. To bridge these gaps in knowledge, we have designed a Phase 2 randomized control trial to test the effects of behavioral and exercise interventions on various outcomes.

Interventions

  • BEHAVIORAL Behavioral Coaching Intervention
  • BEHAVIORAL Virtual Exercise Platform

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2026-04-09
Est. Completion 2033-03-25
Phase NA

Sponsor

University of Nebraska

407 total trials

What the Registry Record Tells You About NCT07292272

The ClinicalTrials.gov registry entry for NCT07292272 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Behavioral Coaching Intervention is the first listed.

NCT07292272 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07292272 about?

NCT07292272 is a clinical study titled "Halt Aging in Survivors of Blood Cancers". Older survivors of blood cancer are at a high risk of accelerated biological aging, which increases their risk of developing multiple aging-related conditions. Whereas physical exercise can improve overall health, older cancer survivors do not meet the recommended physical activity, highlighting the...

What is the current status of trial NCT07292272?

This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2026-04-09. Estimated completion is 2033-03-25.

What interventions are being tested in trial NCT07292272?

The interventions under investigation include: Behavioral Coaching Intervention (BEHAVIORAL), Virtual Exercise Platform (BEHAVIORAL).

Who is sponsoring clinical trial NCT07292272?

This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.